异形性肺纤维化 (IPF):使用新生物标志物的诊断途径
Katarzyna Bartold1, Zofia Iskierko1, Piyush Sindhu Sharma1
1Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
Biomedical journal
|April 24, 2024
概括
诊断异常性肺纤维化 (IPF) 仍然是一个挑战. 本综述探讨了IPF诊断的分子生物标志物,并指出没有单个标志物是特定的,但许多显示出预测和监测疾病的潜力.
科学领域:
- 肺部病理学 肺部病理学
- 生物标志物发现发现
- 医学诊断 医学诊断 医学诊断
背景情况:
- 异形性肺纤维化 (IPF) 诊断往往是一种排除诊断,需要与其他间歇性肺部疾病 (ILD) 进行区分.
- IPF的进展是不可预测的,受遗传因素和预后生物标志物的影响.
- 早期的IPF可能无症状,导致诊断延迟.
研究的目的:
- 对IPF诊断的分子生物标志物的最新文献进行批判性审查.
- 评估各种生物标志物的潜力,以识别和监测IPF.
- 突出IPF生物标志物研究中的挑战和进展.
主要方法:
- 对IPF分子生物标志物的最新文献进行系统审查.
- 生物标志物的分类为呼吸,唾液,血清学,氧化应激,纤维细胞和全血细胞计数标志物.
- 在临床前和临床试验中分析生物标志物的实用性.
主要成果:
- 几类分子生物标志物显示出IPF诊断的前景,包括呼吸,唾液,血清和氧化应激标志物.
- 纤维细胞和完整血清参数正在成为人们感兴趣的领域.
- 迄今为止,没有单一的生物标志物证明了IPF诊断的足够特异性.
结论:
- 虽然没有确定的IPF特定生物标志物,但正在进行的研究和临床试验正在评估各种候选者的预测和监测潜力.
- 生物标志物发现的进步对于改善IPF诊断和患者管理至关重要.
- 需要进一步验证,以确定IPF生物标记物的临床效用.
更多相关视频
相关概念视频
01:26Pulmonary Tuberculosis IV
140
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
140
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K